Stocks recovered on Friday, with all three major indexes in the green, as the tech sector bounced back from Thursday's losses ...

The life sciences industry experienced a dynamic year in 2024. As the public markets gained traction, IPO activity and venture investment saw ...

Novavax, Inc. faces declining revenues and high risks despite the Sanofi deal and cost-cutting measures. Click here for my ...

The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors ...

Moderna is working with Merck to develop a cancer vaccine. Moderna also recently inked a supply deal for its Covid vaccine, Spikevax, in Europe. But Moderna missed its mark in a study of its ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.